Combat validation has become the moat

UFORCE raised $50 million at a billion dollar valuation. Its systems have supported more than 150,000 missions in Ukraine. The second number is why the first one happened.

What investors now underwrite

Something has shifted in what defence investors underwrite. It used to be the technology, the team and the contract pipeline. Increasingly it is whether the thing has been used in a war.

The companies proving it

• UFORCE. Now UK-based, built from 9 Ukrainian companies with manufacturing across 15 locations in 6 European countries. Its MAGURA maritime drones are credited with striking more than 12 Russian warships.

• TEKEVER. Raised $580 million at $6.4 billion last month. Over 50,000 operational flight hours in Ukraine since 2022.

• Alta Ares. Raised €50 million for interceptors already deployed in active combat zones.

The awkward position

Combat validation has become the moat, and it is the one thing capital cannot buy and a demo cannot fake.

Which puts a lot of European defence companies in an awkward spot. If you have not been deployed somewhere difficult, you are competing for the same investors as companies that have.

The question I would be asking if I were building here is not whether the technology works. It is where it has been proven, and who was watching when it did.